HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Stuart Emanuel Selected Research

JNJ-7706621

10/2006Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor.
10/2005The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Stuart Emanuel Research Topics

Disease

8Neoplasms (Cancer)
11/2014 - 09/2004
2Melanoma (Melanoma, Malignant)
11/2014 - 07/2005
1Carcinoma (Carcinomatosis)
10/2006
1Retinoblastoma (Glioblastoma, Retinal)
10/2005

Drug/Important Bio-Agent (IBA)

5Phosphotransferases (Kinase)IBA
06/2011 - 09/2004
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2005 - 09/2004
2aurora kinase (aurora A kinase)IBA
10/2006 - 10/2005
2JNJ-7706621IBA
10/2006 - 10/2005
2Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2006 - 10/2005
1benzamideIBA
11/2014
1matrigelIBA
06/2011
1BMS-690514IBA
06/2011
1PDGF receptor tyrosine kinaseIBA
12/2005
1tyrosine receptor (receptor, tyrosine)IBA
12/2005
1platelet-derived growth factor BB (becaplermin)FDA Link
12/2005
1Aniline CompoundsIBA
12/2005
1CDC2 Protein Kinase (Protein p34cdc2)IBA
10/2005
1P-GlycoproteinIBA
10/2005
1Paclitaxel (Taxol)FDA LinkGeneric
09/2004
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2004
14- (4- (1- Amino- 1- methylethyl)phenyl)- 2- (4- (2- morpholin- 4- yl- ethyl)phenylamino)pyrimidine- 5- carbonitrileIBA
09/2004

Therapy/Procedure

5Heterologous Transplantation (Xenotransplantation)
11/2014 - 09/2004
1Aftercare (After-Treatment)
09/2004